OA12355A - Tartrate salts of thiazolidinedione derivative. - Google Patents

Tartrate salts of thiazolidinedione derivative. Download PDF

Info

Publication number
OA12355A
OA12355A OA1200300029A OA1200300029A OA12355A OA 12355 A OA12355 A OA 12355A OA 1200300029 A OA1200300029 A OA 1200300029A OA 1200300029 A OA1200300029 A OA 1200300029A OA 12355 A OA12355 A OA 12355A
Authority
OA
OAPI
Prior art keywords
meso
tartrate
solvaté
accordance
methyl
Prior art date
Application number
OA1200300029A
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Michael Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of OA12355A publication Critical patent/OA12355A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
OA1200300029A 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative. OA12355A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0019226.0A GB0019226D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
OA12355A true OA12355A (en) 2004-03-19

Family

ID=9897028

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200300029A OA12355A (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative.

Country Status (23)

Country Link
EP (1) EP1307448A1 (ja)
JP (1) JP2004505971A (ja)
KR (1) KR20030022356A (ja)
CN (1) CN1458930A (ja)
AP (1) AP2003002737A0 (ja)
AU (1) AU2001276508A1 (ja)
BG (1) BG107605A (ja)
BR (1) BR0112984A (ja)
CA (1) CA2417828A1 (ja)
CZ (1) CZ2003314A3 (ja)
EA (1) EA200300231A1 (ja)
EC (1) ECSP034468A (ja)
GB (1) GB0019226D0 (ja)
HU (1) HUP0300770A2 (ja)
IL (1) IL154277A0 (ja)
MA (1) MA25830A1 (ja)
MX (1) MXPA03001086A (ja)
NO (1) NO20030508L (ja)
OA (1) OA12355A (ja)
PL (1) PL360702A1 (ja)
SK (1) SK1452003A3 (ja)
WO (1) WO2002012233A1 (ja)
ZA (1) ZA200300962B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
FR2845602B1 (fr) * 2002-10-11 2005-07-08 Servier Lab Association entre un ligand des recepteurs actives par les proliferateurs de peroxisomes et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
US7264813B2 (en) 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102532122B (zh) * 2010-12-29 2015-12-02 开封制药(集团)有限公司 酒石酸罗格列酮的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
AU2001276508A1 (en) 2002-02-18
BR0112984A (pt) 2003-06-10
JP2004505971A (ja) 2004-02-26
EP1307448A1 (en) 2003-05-07
NO20030508L (no) 2003-03-20
KR20030022356A (ko) 2003-03-15
GB0019226D0 (en) 2000-09-27
SK1452003A3 (en) 2004-05-04
WO2002012233A1 (en) 2002-02-14
HUP0300770A2 (hu) 2003-11-28
PL360702A1 (en) 2004-09-20
MA25830A1 (fr) 2003-07-01
NO20030508D0 (no) 2003-01-31
CN1458930A (zh) 2003-11-26
CZ2003314A3 (cs) 2004-02-18
MXPA03001086A (es) 2003-05-27
BG107605A (bg) 2003-09-30
ZA200300962B (en) 2003-10-29
IL154277A0 (en) 2003-09-17
ECSP034468A (es) 2003-03-31
EA200300231A1 (ru) 2003-06-26
AP2003002737A0 (en) 2003-03-31
CA2417828A1 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
US20040048899A1 (en) Tartrate salts of thiazollidnedione derivative
OA12355A (en) Tartrate salts of thiazolidinedione derivative.
US20070185167A1 (en) Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
EP1305311B1 (en) Tartrate salt of thiazolidinedione derivative
EP1315721B1 (en) A thiazolidinedione derivative and its use as antidiabetic
WO2003050113A1 (en) Hydrogensulfate salt of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy!benzyl!thia zolidine-2,4-dione
OA12284A (en) Thiazolidinedione salt for treatment of diabetes mellitus.
US20040102485A1 (en) Tartrate salt of thiazolidinedione derivative
US20040038968A1 (en) Thiazolidinedione derivative and its use as antidiabetic
US20040087629A1 (en) Tartrate salts of thiazolidinedione derivative
WO2003050112A1 (en) Toluenesulfonate hydrates of a thiazolidinedione derivative
WO2003050111A1 (en) Toluenesulfonate salts of a thiazolidinedione derivative
WO2003050116A1 (en) A 5(-4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione (i) 10-camphorsulphonic acid salt and use against diabetes mellitus
WO2003050114A1 (en) Sulfate salt of a thiazolidinedione derivative
WO2003053963A1 (en) Novel pharmaceutical
WO2003053965A1 (en) Salicylate salt of a thiazolidinedione derivative